Successful treatment of two relapsed patients with t(11;19)(q23;p13) acute myeloid leukemia by CLAE chemotherapy sequential with allogeneic hematopoietic stem cell transplantation: Case reports

The prognosis of patients with relapsed/refractory acute myeloid leukemia (R/R AML) is poor, with a 3-year overall survival rate of 10%. Patients with translocation (t)(11;19)(q23;p13) have a higher risk of relapse and there is no optimal regimen for these patients. The present study treated two you...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Shandong, Song, Lixiao, Deng, Yuan, Chen, Yue, Gan, Yimin, Li, Yunjie, Ding, Yihan, Zhang, Zhe, Ding, Banghe, He, Zhengmei, Wang, Chunling, Yu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816337/
https://www.ncbi.nlm.nih.gov/pubmed/33574917
http://dx.doi.org/10.3892/ol.2021.12439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816337/
https://www.ncbi.nlm.nih.gov/pubmed/33574917
http://dx.doi.org/10.3892/ol.2021.12439

Ejemplares similares